SHINKEI is a clinical stage CNS (Central Nervous System) disorders focused pharmaceutical company using the 505(b)2 regulatory strategy to repurpose existing pharmaceutical products for faster and better patient outcome. We have a diversified and robust product development pipeline focus on improving a drug’s administration such that it allows use in indications not previously possible, enhances the convenience, improves compliance, and/or ameliorates the side-effects profile for patients SHINKEI was co-founded by Suresh Borsadia and GP Singh, industry veterans, having the mix of commercial and scientific backgrounds. They are supported by a nimble and efficient team of professionals, advisors and consultants.
View Top Employees from SHINKEI TherapeuticsWebsite | http://www.shinkeitherapeutics.com |
Employees | 4 (1 on RocketReach) |
Founded | 2017 |
Address | 303a College Rd E, Princeton, New Jersey 08540, US |
Technologies |
JavaScript,
HTML,
PHP
+6 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, 505(b)(2), CNS, Neurology, Drug Development, Traumatic Brain Injury, Pseudobulbar Affect, Neurological Disorders, Movement Disorders, Huntington's Disease, Pharmaceutical Development, Drug Delivery, Pharmaceutical Innovation |
Looking for a particular SHINKEI Therapeutics employee's phone or email?
1 people are employed at SHINKEI Therapeutics.
SHINKEI Therapeutics is based in Princeton, New Jersey.